Related Experiment Video
Updated: Jun 10, 2025
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
Optimization and intra-assay validation of a multiparametric flow cytometric test for monitoring circulating TREGs
Iole Macchia1, Floriana Iacobone1, Francesca Urbani1
1Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), Rome, Italy.
Insights
This study validates an 8-color flow cytometry protocol for accurately detecting regulatory T cells (TREGs), crucial for immune monitoring in research and clinical settings. The validated method ensures reliable TREG cell frequency and function analysis.
Area of Science:
- Immunology
- Cell Biology
- Clinical Research
Background:
- Multiparametric flow cytometry (MFC) is vital for immune monitoring.
- Regulatory T cells (TREGs) are critical immune modulators in various diseases.
- Accurate TREG detection is essential for cancer immunotherapy and autoimmune disease research.
Purpose of the Study:
- To validate an 8-color flow cytometry protocol for TREG detection and analysis.
- To establish a robust assay for TREG cell frequency and function in a real-world laboratory.
- To provide a detailed standard operating procedure for TREG analysis.
Main Methods:
- Development and validation of an 8-color flow cytometry panel.
- Standardized workflow including panel design, staining, acquisition, and analysis.
- Intra-assay accuracy testing on fresh whole blood samples from healthy subjects.
Main Results:
- Successful validation of an 8-color flow cytometry protocol for TREG analysis.
- Demonstrated intra-assay accuracy for reliable TREG quantification.
- Comprehensive standard operating procedure with troubleshooting guidance.
Conclusions:
- The validated MFC protocol provides a reliable method for TREG detection.
- This assay is suitable for routine laboratory use, translational, and clinical research.
- Accurate TREG analysis supports advancements in immunotherapy and understanding immune responses.
Abstract:
Multiparametric flow cytometry (MFC) represents an essential tool for immune monitoring, and validation of MFC panels is a fundamental prerequisite in routine laboratory settings as well as for translational and clinical research purposes. Regulatory T cells (TREGs) constitute a subset of CD4+ effector T cells that modulate the immune response in numerous settings, including autoimmune disease, allergy, microbial infection, tumor immunity, transplantation, and more. These cells comprise a small fraction of total CD4+ T cells in human peripheral blood and mouse spleen. In oncology, TREG cells are highly relevant, as they are involved in the suppression of the anti-tumor response in many types of cancer, to the extent that the first immune checkpoint inhibitor approved for clinical use in humans was a monoclonal antibody directed against CTLA-4, a molecule functionally associated with TREGs. Due to all these factors, robust assays are mandatory to accurately determine TREG cell frequency and function. Here, we describe the validation of an 8-color flow-cytometry protocol for TREG detection and analysis in a real-world laboratory scenario. The entire process includes the workflow plan and the standard operating procedure resembling each phase, from the panel design to the staining, acquisition, and analysis steps. Validation is planned to be performed in replicates on fresh whole blood samples derived from multiple healthy subjects. The analytical validity of the TREG cell assay is ensured by testing the intra-assay accuracy. The detailed procedure for the entire process is accompanied by important troubleshooting suggestions and other useful tips.
